Response to: "Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time".
作者信息
Kvitne Kine Eide, Hole Kristine, Molden Espen, Robertsen Ida
机构信息
Section for Pharmacology, Pharmaceutical Biosciences, Department of Pharmacy, University of Oslo, Blindern, P.O. Box 1068, 0316, Oslo, Norway.
Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
出版信息
Eur J Clin Pharmacol. 2022 Nov;78(11):1865-1866. doi: 10.1007/s00228-022-03387-y. Epub 2022 Sep 13.
Abstract
摘要
相似文献
1
Response to: "Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time".对《内源性4β-羟基胆固醇作为评估细胞色素P450 3A（CYP3A）活性生物标志物的效用：尚未完全准备好进入黄金时代》的回应
Eur J Clin Pharmacol. 2022 Nov;78(11):1865-1866. doi: 10.1007/s00228-022-03387-y. Epub 2022 Sep 13.
2
Utility of endogenous 4β-hydroxycholesterol as a biomarker to assess cytochrome P 450 3A (CYP3A) activity: not quite ready for prime time.内源性4β-羟基胆固醇作为评估细胞色素P450 3A（CYP3A）活性生物标志物的效用：尚未完全准备好进入黄金时期。
Eur J Clin Pharmacol. 2022 Nov;78(11):1863-1864. doi: 10.1007/s00228-022-03386-z. Epub 2022 Sep 13.
3
Evaluation of 4β-Hydroxycholesterol and 25-Hydroxycholesterol as Endogenous Biomarkers of CYP3A4: Study with CYP3A-Humanized Mice.评价 4β-羟胆固醇和 25-羟胆固醇作为 CYP3A4 内源性生物标志物的研究：用 CYP3A 人源化小鼠进行的研究。
AAPS J. 2018 Apr 9;20(3):61. doi: 10.1208/s12248-018-0186-9.
4
4β-Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation.4β-羟基胆固醇作为 CYP3A 活性的内源性生物标志物：文献综述与批判性评价。
J Clin Pharmacol. 2019 May;59(5):611-624. doi: 10.1002/jcph.1391. Epub 2019 Feb 12.
5
Perspective: 4β-hydroxycholesterol as an emerging endogenous biomarker of hepatic CYP3A.观点：4β-羟基胆固醇作为肝 CYP3A 的新兴内源性生物标志物。
Drug Metab Rev. 2017 Feb;49(1):18-34. doi: 10.1080/03602532.2016.1239630. Epub 2016 Oct 20.
6
4β-Hydroxycholesterol as an endogenous biomarker of CYP3A activity in cynomolgus monkeys.4β-羟基胆固醇作为食蟹猴CYP3A活性的内源性生物标志物。
Drug Metab Dispos. 2014 May;42(5):839-43. doi: 10.1124/dmd.114.057224. Epub 2014 Mar 4.
7
Sensitive UHPLC-MS/MS quantification method for 4β- and 4α-hydroxycholesterol in plasma for accurate CYP3A phenotyping.用于准确 CYP3A 表型分析的血浆中 4β-和 4α-羟基胆固醇的灵敏 UHPLC-MS/MS 定量方法。
J Lipid Res. 2022 Mar;63(3):100184. doi: 10.1016/j.jlr.2022.100184. Epub 2022 Feb 16.
8
Use of 4β-Hydroxycholesterol Plasma Concentrations as an Endogenous Biomarker of CYP3A Activity: Clinical Validation in Individuals With Type 2 Diabetes.将 4β-羟基胆固醇血浆浓度用作 CYP3A 活性的内源性生物标志物的应用：2 型糖尿病个体的临床验证。
Clin Pharmacol Ther. 2019 Oct;106(4):831-840. doi: 10.1002/cpt.1472. Epub 2019 Jun 5.
9
Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio.妊娠可使 CYP3A 酶活性增加，可通过 4β-羟胆固醇/胆固醇比值来衡量。
Int J Mol Sci. 2022 Dec 2;23(23):15168. doi: 10.3390/ijms232315168.
10
Cytochrome P450 3A activity in mothers and their neonates as determined by plasma 4β-hydroxycholesterol.通过测定血浆 4β-羟胆固醇来评估母亲及其新生儿细胞色素 P450 3A 的活性。
Eur J Clin Pharmacol. 2011 Jul;67(7):715-22. doi: 10.1007/s00228-010-0984-1. Epub 2011 Jan 19.
引用本文的文献
1
Cytochrome P450 activity in rheumatoid arthritis patients during continuous IL-6 receptor antagonist therapy.类风湿关节炎患者在持续接受白细胞介素 6 受体拮抗剂治疗期间细胞色素 P450 的活性。
Eur J Clin Pharmacol. 2023 Dec;79(12):1687-1698. doi: 10.1007/s00228-023-03578-1. Epub 2023 Oct 13.
本文引用的文献
1
Correlations between 4β-hydroxycholesterol and hepatic and intestinal CYP3A4: protein expression, microsomal ex vivo activity, and in vivo activity in patients with a wide body weight range.4β-羟胆固醇与肝和肠道 CYP3A4 的相关性：在广泛体重范围内的患者中的蛋白表达、离体 microsomal 活性和体内活性。
Eur J Clin Pharmacol. 2022 Aug;78(8):1289-1299. doi: 10.1007/s00228-022-03336-9. Epub 2022 Jun 1.
2
Effect of Grapefruit Juice Intake on Serum Level of the Endogenous CYP3A4 Metabolite 4β-Hydroxycholesterol-an Interaction Study in Healthy Volunteers.摄入柚子汁对健康志愿者体内内源性 CYP3A4 代谢物 4β-羟基胆固醇血清水平的影响——一项相互作用研究。
AAPS J. 2019 Apr 24;21(4):58. doi: 10.1208/s12248-019-0330-1.
3
4β-Hydroxycholesterol as an Endogenous Biomarker for CYP3A Activity: Literature Review and Critical Evaluation.4β-羟基胆固醇作为 CYP3A 活性的内源性生物标志物：文献综述与批判性评价。
J Clin Pharmacol. 2019 May;59(5):611-624. doi: 10.1002/jcph.1391. Epub 2019 Feb 12.
4
Higher Midazolam Clearance in Obese Adolescents Compared with Morbidly Obese Adults.肥胖青少年咪达唑仑清除率高于病态肥胖成年人。
Clin Pharmacokinet. 2018 May;57(5):601-611. doi: 10.1007/s40262-017-0579-4.
5
Semiphysiologically based pharmacokinetic model for midazolam and CYP3A mediated metabolite 1-OH-midazolam in morbidly obese and weight loss surgery patients.病态肥胖及减肥手术患者中咪达唑仑和CYP3A介导的代谢物1-羟基咪达唑仑的半生理药代动力学模型
CPT Pharmacometrics Syst Pharmacol. 2016 Jan;5(1):20-30. doi: 10.1002/psp4.12048. Epub 2015 Dec 18.
6
Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach.人类药物代谢酶和转运体的适当表型分析程序及其在“鸡尾酒”法中的同时应用。
Clin Pharmacol Ther. 2007 Feb;81(2):270-83. doi: 10.1038/sj.clpt.6100050.
7
An evaluation of the suitability of intravenous midazolam as an in vivo marker for hepatic cytochrome P4503A activity.静脉注射咪达唑仑作为肝细胞色素P4503A活性体内标志物的适用性评估。
Clin Pharmacol Ther. 2003 Mar;73(3):153-8. doi: 10.1067/mcp.2003.23.
Zotero 插件